Lung function in adult patients with osteogenesis imperfecta: a cohort study.
Détails
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_CE731B2BB052
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Lung function in adult patients with osteogenesis imperfecta: a cohort study.
Périodique
Orphanet journal of rare diseases
ISSN
1750-1172 (Electronic)
ISSN-L
1750-1172
Statut éditorial
Publié
Date de publication
04/12/2024
Peer-reviewed
Oui
Volume
19
Numéro
1
Pages
455
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Publication Status: epublish
Résumé
Osteogenesis imperfecta (OI) is a rare hereditary bone disease resulting from a defect in collagen synthesis or processing, leading to bone fragility, frequent fractures and skeletal deformities. OI is associated with increased respiratory morbidity and mortality, but the mechanisms of lung involvement are poorly understood, and there are no data on the natural history of lung function. We studied lung function over time in a cohort of adult OI patients at one center.
We used data from OI patients aged 15 and above followed up at the Lausanne university hospital between 2012 and 2023 with available pre-bronchodilator spirometry. Associations between spirometric measurements at first visit and clinical characteristics were studied through linear regression. Changes of spirometric variables over time were analysed through mixed linear regression. Models were adjusted for age, sex, height and OI type (Sillence classification).
Among 46 subjects, 24% had impaired spirometry at baseline, with similar distribution between restrictive (8.7%), obstructive (8.7%) and mixed (6.5%) ventilatory patterns. At first visit, higher age was associated with lower FEV <sub>1</sub> (β = -0.019 l, p = 0.014) and lower FEV <sub>1</sub> /FVC (β = -0.175%, p = 0.012). A history of asthma was associated with higher FEV <sub>1</sub> (β = 0.636 l, p = 0.028) and FVC (β = 0.834 l, p = 0.010). At first visit, FEV <sub>1</sub> (β = -0.750 l, p = 0.006) and FVC (β = -0.859 l, p = 0.004) was lower in individuals with OI Sillence types 3, 4 or 5 compared to type 1. Over a mean follow-up of 3.4 years, smokers had a greater decline of FEV <sub>1</sub> /FVC compared to non-smokers (β = -6.592%, p = 0.007). Individuals with a mutation in the gene COL1A2 had 740 ml lower FVC compared to those with a mutation in COL1A1 (p = 0.037). After adjustment for sex, age, height and OI type, FEV <sub>1</sub> increased by 26 ml (95% CI 8; 45) or 1.28%pred (0.51; 2.05) and FVC increased by 25 ml (95% CI 8; 43) or 0.93%pred (0.31; 1.55) per year of follow-up.
An increase of FEV <sub>1</sub> and FVC over time was observed in OI patients after adjustment for other variables, suggesting that the defective collagen synthesis may impact the pulmonary interstitium and lead to increased lung compliance and hyperinflation, in contrast to skeletal deformities, which reduce the thoracic volume. Lung function changes in OI thus result from the interplay of several mechanisms.
We used data from OI patients aged 15 and above followed up at the Lausanne university hospital between 2012 and 2023 with available pre-bronchodilator spirometry. Associations between spirometric measurements at first visit and clinical characteristics were studied through linear regression. Changes of spirometric variables over time were analysed through mixed linear regression. Models were adjusted for age, sex, height and OI type (Sillence classification).
Among 46 subjects, 24% had impaired spirometry at baseline, with similar distribution between restrictive (8.7%), obstructive (8.7%) and mixed (6.5%) ventilatory patterns. At first visit, higher age was associated with lower FEV <sub>1</sub> (β = -0.019 l, p = 0.014) and lower FEV <sub>1</sub> /FVC (β = -0.175%, p = 0.012). A history of asthma was associated with higher FEV <sub>1</sub> (β = 0.636 l, p = 0.028) and FVC (β = 0.834 l, p = 0.010). At first visit, FEV <sub>1</sub> (β = -0.750 l, p = 0.006) and FVC (β = -0.859 l, p = 0.004) was lower in individuals with OI Sillence types 3, 4 or 5 compared to type 1. Over a mean follow-up of 3.4 years, smokers had a greater decline of FEV <sub>1</sub> /FVC compared to non-smokers (β = -6.592%, p = 0.007). Individuals with a mutation in the gene COL1A2 had 740 ml lower FVC compared to those with a mutation in COL1A1 (p = 0.037). After adjustment for sex, age, height and OI type, FEV <sub>1</sub> increased by 26 ml (95% CI 8; 45) or 1.28%pred (0.51; 2.05) and FVC increased by 25 ml (95% CI 8; 43) or 0.93%pred (0.31; 1.55) per year of follow-up.
An increase of FEV <sub>1</sub> and FVC over time was observed in OI patients after adjustment for other variables, suggesting that the defective collagen synthesis may impact the pulmonary interstitium and lead to increased lung compliance and hyperinflation, in contrast to skeletal deformities, which reduce the thoracic volume. Lung function changes in OI thus result from the interplay of several mechanisms.
Mots-clé
Humans, Osteogenesis Imperfecta/physiopathology, Osteogenesis Imperfecta/genetics, Male, Adult, Female, Cohort Studies, Middle Aged, Lung/physiopathology, Young Adult, Spirometry, Respiratory Function Tests, Adolescent, Cohort studies, Lung diseases/physiopathology, Osteogenesis imperfecta
Pubmed
Web of science
Open Access
Oui
Création de la notice
09/12/2024 10:25
Dernière modification de la notice
21/01/2025 8:27